1. Home
  2. BOLD vs LITB Comparison

BOLD vs LITB Comparison

Compare BOLD & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • LITB
  • Stock Information
  • Founded
  • BOLD 2018
  • LITB 2007
  • Country
  • BOLD United States
  • LITB Singapore
  • Employees
  • BOLD N/A
  • LITB N/A
  • Industry
  • BOLD
  • LITB Catalog/Specialty Distribution
  • Sector
  • BOLD
  • LITB Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • LITB Nasdaq
  • Market Cap
  • BOLD 30.3M
  • LITB 32.7M
  • IPO Year
  • BOLD 2024
  • LITB N/A
  • Fundamental
  • Price
  • BOLD $1.05
  • LITB $1.16
  • Analyst Decision
  • BOLD Buy
  • LITB
  • Analyst Count
  • BOLD 3
  • LITB 0
  • Target Price
  • BOLD $4.00
  • LITB N/A
  • AVG Volume (30 Days)
  • BOLD 205.8K
  • LITB 13.1K
  • Earning Date
  • BOLD 08-11-2025
  • LITB 08-01-2025
  • Dividend Yield
  • BOLD N/A
  • LITB N/A
  • EPS Growth
  • BOLD N/A
  • LITB N/A
  • EPS
  • BOLD N/A
  • LITB 0.08
  • Revenue
  • BOLD N/A
  • LITB $231,136,000.00
  • Revenue This Year
  • BOLD N/A
  • LITB N/A
  • Revenue Next Year
  • BOLD N/A
  • LITB N/A
  • P/E Ratio
  • BOLD N/A
  • LITB $14.66
  • Revenue Growth
  • BOLD N/A
  • LITB N/A
  • 52 Week Low
  • BOLD $1.01
  • LITB $0.91
  • 52 Week High
  • BOLD $6.24
  • LITB $5.76
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • LITB 44.38
  • Support Level
  • BOLD N/A
  • LITB $1.16
  • Resistance Level
  • BOLD N/A
  • LITB $1.32
  • Average True Range (ATR)
  • BOLD 0.00
  • LITB 0.08
  • MACD
  • BOLD 0.00
  • LITB 0.01
  • Stochastic Oscillator
  • BOLD 0.00
  • LITB 14.71

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: